Gastrointestinal precancerous lesions (GPLs), including Barretts esophagus, chronic atrophic gastritis (CAG), gastric intestinal metaplasia (GIM), aberrant crypt foci (ACF), and colorectal adenomas are a series of pathological conditions associated with a significant risk of malignant transformation 3
Avoiding Common Timing Mistakes That Reduce GLP-1 Effectiveness One frequent error is inconsistent dosing timing: taking your injection or oral medication at dramatically different times week to week disrupts your body's adaptation and can worsen side effects like nausea or fatigue
McLean BA, Wong CK, Kabir MG, Drucker DJ (2022) Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction
Use appropriate syringes and needles (typically 4-6mm length, 31-32 gauge for subcutaneous delivery)
Patients on 2.4 mg (Wegovy dose) or 2 mg (common compounded dose) have less safety margin